The Effect of Melatonin Application Following Removal of Impacted Third Molar
NCT ID: NCT04424875
Last Updated: 2021-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
38 participants
INTERVENTIONAL
2020-07-01
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Melatonin Patches on Dental Anxiety in Children
NCT07162272
Intraosseous vs Submucosal Injection of Dexamethasone
NCT04718077
Effects of Melatonin and Massage After Third Molar Surgery
NCT06812026
Effect of Honey and Dexamethason on Extraction Healing
NCT04848259
Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery
NCT04791943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study arm
patients will undergo surgery to remove impacted lower third molar and receive Melatonin (3 mg melatonin into 2 ml hydroxyethyl cellulose gel 2%) in the socket following removal of the impacted third molar
3 mg melatonin
patients will remove impacted third molar and receive 3 mg melatonin into 2 ml hydroxyethyl cellulose gel 2%
controlled arm
patients will undergo surgery to remove impacted lower third molar and patients will receive no melatonin (2 ml of hydroxyethyl cellulose gel 2 %).
Placebo
patients will remove impacted third molar and receive 2 ml hydroxyethyl cellulose gel 2%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3 mg melatonin
patients will remove impacted third molar and receive 3 mg melatonin into 2 ml hydroxyethyl cellulose gel 2%
Placebo
patients will remove impacted third molar and receive 2 ml hydroxyethyl cellulose gel 2%
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no systemic disease
* impacted mandibular third molar class II position B on Pell- Gregory classification
Exclusion Criteria
* local infection,
* tobacco use,
* oral contraceptive,
* pregnancy and lactation
* patients who had taken analgesics or anti-inflammatories for 1 week prior to enrollment in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fayoum University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Mohsen
lecturer,oral surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Cobo-Vazquez C, Fernandez-Tresguerres I, Ortega-Aranegui R, Lopez-Quiles J. Effects of local melatonin application on post-extraction sockets after third molar surgery. A pilot study. Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19(6):e628-33. doi: 10.4317/medoral.19851.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Melatonin and 3rd molar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.